# Aclaris Therapeutics, Inc.: Form 8-K, filed Oct 27, 2026

- Company: [Aclaris Therapeutics, Inc.](/companies/acrs.md) (CIK 1557746)
- Form: 8-K
- Filed: 2026-10-27
- Accepted by EDGAR: Oct 27, 2026, 17:25 ET
- Period: 2026-10-27
- Accession: 0001104659-26-119231
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1557746/000110465926119231/tm2628355d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1557746/000110465926119231/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1557746/000110465926119231/tm2628355d1_8k.htm

Filed Oct 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-119231. Last ingested by Listed: Nov 5, 2026, 18:44 ET. No prices; not investment advice.